CVA Family Office’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
CVA Family Office's AMGN Position: Q2 2026 in Review
CVA Family Office reduced its Amgen (AMGN) stake by 0.1% in Q2 2026, selling an estimated $1.37K and leaving 4,049 shares worth $1.47M. The position accounts for 0.13% of the portfolio, ranked #98.
CVA Family Office first reported a position in AMGN in Q1 2020 and has held it in 26 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- CVA Family Office held 4,049 shares of Amgen worth $1.47M as of Q2 2026.
- CVA Family Office sold 4 Amgen shares in Q2 2026, an estimated $1.37K.
- Amgen made up 0.13% of CVA Family Office's portfolio in Q2 2026, its #98 holding.
- CVA Family Office first reported a position in Amgen in Q1 2020 and has held it in 26 quarters since.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.